Sort   by:  
 Page size 
UnknownTherapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.
Not available
S-EPMC8362592 | biostudies-literature
UnknownCirculating natriuretic peptide concentrations reflect changes in insulin sensitivity over time in the Diabetes Prevention Program.
Not available
S-EPMC4158711 | biostudies-literature
UnknownConfirming glycemic status in the Diabetes Prevention Program: implications for diagnosing diabetes in high risk adults.
Not available
S-EPMC3594066 | biostudies-literature
UnknownGenomic epidemiology of SARS-CoV-2 in a UK university identifies dynamics of transmission.
Not available
S-EPMC8826310 | biostudies-literature
UnknownExtension of type 2 diabetes genome-wide association scan results in the diabetes prevention program.
Not available
S-EPMC2518503 | biostudies-literature
UnknownChanges in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study.
Not available
S-EPMC8041365 | biostudies-literature
UnknownGenomic assessment of quarantine measures to prevent SARS-CoV-2 importation and transmission.
Not available
S-EPMC8866425 | biostudies-literature
UnknownGenetic modulation of lipid profiles following lifestyle modification or metformin treatment: the Diabetes Prevention Program.
Not available
S-EPMC3431328 | biostudies-literature
UnknownDiabetes autoantibodies do not predict progression to diabetes in adults: the Diabetes Prevention Program.
Not available
S-EPMC4138247 | biostudies-literature
UnknownSARS-CoV-2 evolution during treatment of chronic infection.
Not available
S-EPMC7610568 | biostudies-literature
Sort   by:  
 Page size